SnapGene and Synbio Technologies Partner to Streamline Construct Design and Synthesis

SnapGene customers can now order synthetic biology constructs directly from the software through Synbio Technologies.

CHICAGO--()--Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to order constructs directly from Synbio Technologies after having designed them in SnapGene. GSL Biotech developed SnapGene to aid the visualization, design, and documentation of DNA cloning, Gibson assembly, mutagenesis, and a growing list of additional molecular biology procedures that now includes synthetic biology. With this collaboration, the constructs designed with SnapGene software can be easily and accurately ordered from Synbio Technologies.

“We think that the combination of SnapGene’s synthetic biology interface and Synbio’s Syno® DNA Synthesis Platform will be a powerful toolset for streamlining synthetic biology procedures in labs all over the world.”

“We are excited to partner with Synbio Technologies ”, said Aline Glick, Vice President of Product Management at GSL Biotech. “We think that the combination of SnapGene’s synthetic biology interface and Synbio’s Syno® DNA Synthesis Platform will be a powerful toolset for streamlining synthetic biology procedures in labs all over the world.”

“SnapGene offers a unique approach to laboratory procedures, and we are thrilled to partner with them,” said Yi Du, Marketing Director at Synbio Technologies. “Customers will use the revolutionary SnapGene software to design their DNA construct specific to their research interests, allowing Synbio Technologies to synthesize the final product. We at Synbio Technologies are excited for the unique opportunity to be listed as a vendor on the SnapGene software.”

About GSL Biotech:

GSL Biotech was founded by scientists and software designers to meet the everyday needs of molecular biologists. GSL's SnapGene desktop software (snapgene.com) is used in virtually every major research institution, and in more than half of the largest pharmaceutical and biotech companies worldwide. The software provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures. Free trials of the software are available from the SnapGene website.

In addition to SnapGene, GSL Biotech offers the free SnapGene Viewer, which includes the key visualization tools of SnapGene and allows researchers to make DNA maps and design primers, as well as SnapGene Server, which allows interactive DNA maps to be displayed in a web browser.

For more information, please visit https://www.snapgene.com/.

About Synbio Technologies:

At Synbio Technologies we are always searching for more optimal ways to fulfill our customer’s molecular and synthetic biology requests within an efficient turnaround time. We accomplish this goal through our wide range of molecular and synthetic biology services. These services include gene synthesis, plasmid preparation, PCR cloning, subcloning, site-directed mutagenesis, and vector construction. Synbio Technologies then takes these molecular biology procedures and services one step further with our Syno® Synthesis Platform. With this platform, we are capable of synthesizing even the most complex genetic sequences up to and including 150kb long with 100% accuracy. It is the Syno® Synthesis Platform Technology that Synbio Technologies will offer SnapGene’s users to synthesize their designed DNA construct. This also allows Synbio Technologies to cater to the SnapGene user’s request for their molecular and synthetic biology needs.

For more information on Synbio Technologies and our molecular and synthetic biology services, please visit our website: http://www.synbio-tech.com/.

Contacts

GSL Biotech
Aline Glick
aglick@snapgene.com
or
Synbio Technologies
Jenny Tang
jiyu.tang@synbio-tech.com

Recent Stories

RSS feed for GSL Biotech

Release Summary

SnapGene Offers Fulfillment of Synthetic Biology Constructs by Synbio Technologies

GSL Biotech